Clinical Trials Browser

Unknown × Interventional × Everolimus × Clear all

NCT06317298 2024-03-19

Fruquintinib Plus Everolimus as 2nd Line Therapy of ccRCC Patients Progressed Post IO and TKI Therapy

Phase NA Unknown

Carcinoma, Renal Cell

NCT04591431 2023-10-03

ROME

Phase 2 Unknown

BreastGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms

NCT02687958 2023-05-30

Study of Everolimus as Maintenance Therapy for Metastatic NEC With Pulmonary or Gastroenteropancreatic Origin

Phase 2 Unknown

Carcinoma, Neuroendocrine

NCT03805399 2022-08-10

FUTURE

Phase 1/2 Unknown

Triple Negative Breast Neoplasms

NCT04355858 2022-07-26

MULAN

Phase 2 Unknown

Breast Neoplasms, Neoplasm Metastasis

NCT05429684 2022-06-23

Precise Therapy for Refractory HER2 Positive Advanced Breast Cancer

Phase 3 Unknown

HER2+ Breast Cancer

NCT03239015 2022-03-04

Efficacy and Safety of Precision Therapy in Refractory Tumor

Phase 2 Unknown

Neoplasms

NCT05124431 2021-11-18

ALTER-UC-001

Phase 2 Unknown

Carcinoma, Renal Cell

NCT01263951 2021-10-26

Study of Everolimus and Sorafenib in Patients With Advanced Thyroid Cancer Who Progressed on Sorafenib Alone

Phase 2 Unknown

EndocrineHead & Neck

Differentiated Thyroid Cancer

NCT02294006 2021-09-09

MetNET1

Phase 2 Unknown

Adenoma, Islet Cell

NCT02695459 2021-04-20

Cisplatinum and Everolimus in Patients With Metastatic or Unresectable NEC of Extrapulmonary Origin

Phase 2 Unknown

Carcinoma, Neuroendocrine

NCT03095040 2021-02-08

CM082 Combined With Everolimus in Chinese Patients With Metastatic Renal Cell Carcinoma

Phase 3 Unknown

Renal Cell Cancer Metastatic

NCT02638428 2020-03-19

Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy

Phase 2 Unknown

Other solid neoplasm

Relapsed Pediatric Solid Tumor

NCT02109913 2019-10-14

Analysis of Tumor Tissue and Circulating Genetic Material in the Blood to Obtain Further Insight in the Effectiveness of Everolimus When Combined With Exemestane

Phase NA Unknown

Breast Neoplasms, Neoplasm Metastasis

NCT03629847 2018-08-14

Treatment of Neuroendocrine Tumors (NETs) With Combination of Everolimus and Radiolabeled Somatostatin Analogue

Phase 1/2 Unknown

Metatropic dwarfism, Neuroendocrine Tumors

NCT02233049 2018-07-23

BIOMEDE

Phase 2 Unknown

Diffuse Intrinsic Pontine Glioma

NCT03580239 2018-07-09

Everolimus in Castrated Resistant Prostate Cancer(CRPC)Patients With PI3K-AKT-mTOR Signaling Pathway Deficiency

Phase 3 Unknown

Prostatic Neoplasms

NCT02836847 2018-05-07

Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

Phase 2 Unknown

Gastrointestinal

Gallbladder Neoplasms

NCT01341834 2018-04-24

Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven Tumors

Phase 1 Unknown

Head & NeckLymphoid

Nasopharyngeal Carcinoma, Lymphoma, Hereditary Sensory and Autonomic Neuropathies

NCT01954693 2018-01-30

TRON

Phase 2 Unknown

Tuberous Sclerosis

NCT01283789 2017-02-08

Lapatinib and RAD-001 for HER2 Positive Metastatic Breast Cancer

Phase 2 Unknown

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT02015728 2016-12-15

SEED

Phase NA Unknown

Neoplasms, Recurrence

NCT00499603 2016-11-01

Paclitaxel Followed by FEC Versus Paclitaxel and RAD001 Followed by FEC In Women With Breast Cancer

Phase 2 Unknown

62 enrolled 13 charts

Breast Neoplasms

NCT02013089 2016-08-30

GITIC

Phase NA Unknown

Gastrointestinal

Gastrointestinal Neoplasms

NCT02404051 2016-06-15

FEVEX

Phase 3 Unknown

Breast Neoplasms, Neoplasm Metastasis

NCT02616848 2015-11-30

Safety and Tolerability of Everolimus in Combination With Eribulin in Triple-negative Breast Cancers

Phase 1 Unknown

Triple Negative Breast Neoplasms

NCT02450175 2015-05-21

Etiology of the Platelet-Cancer Metastatic Pathway - A Study of Inflammatory Markers, Platelet Characteristics and Metastatic Surrogates in Cancer Patients and Controls

Phase NA Unknown

Neoplasm Metastasis, Neoplasms

NCT02188550 2015-05-19

Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer

Phase 2 Unknown

Ovarian Neoplasms, Recurrence, Endometrial Neoplasms

NCT01730209 2015-05-05

RAPIT

Phase 2/3 Unknown

Autistic Disorder, Intellectual Disability, Tuberous Sclerosis

NCT01960829 2015-05-01

Everolimus in Selected Patients With Metastatic Melanoma: Efficacy and Safety Study

Phase 2 Unknown

Melanoma, Neoplasm Metastasis

NCT02313051 2014-12-09

MIRACLE

Phase 2 Unknown

Breast Neoplasms

NCT02208128 2014-08-04

MORE

Phase NA Unknown

Carcinoma, Renal Cell

NCT02025712 2014-01-01

Exemestane Plus Everolimus for Hormone-receptor Positive Metastatic Breast Cancer

Phase 2 Unknown

BreastOther neoplasm

Hormone Receptor Positive Malignant Neoplasm of Breast

NCT00544999 2013-09-17

Everolimus, Cytarabine, and Daunorubicin in Treating Patients With Relapsed Acute Myeloid Leukemia

Phase 1 Unknown

Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

NCT01932177 2013-08-30

EVESOR

Phase 1 Unknown

Neoplasm Metastasis

NCT01118065 2013-08-12

Everolimus in Treating Patients With Progressive or Recurrent, Unresectable, or Metastatic Thyroid Cancer

Phase 2 Unknown

EndocrineHead & Neck

Thyroid Cancer, Papillary, Head and Neck Neoplasms, Thyroid Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary, Thyroid Carcinoma, Anaplastic

NCT01216826 2013-08-07

Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed Osteosarcoma

Phase 2 Unknown

Osteosarcoma

NCT01216839 2013-03-26

Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed Rhabdomyosarcoma and Other Soft Tissue Sarcomas

Phase 2 Unknown

Sarcoma

NCT00636922 2013-02-15

Everolimus (RAD001) in Elderly Patients With Acute Myeloid Leukemia

Phase 1 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00466102 2012-08-30

RADAR

Phase 2 Unknown

Breast Neoplasms

NCT01423708 2012-07-18

EPOCAL

Phase 2 Unknown

Gastrointestinal

Liver Cirrhosis, Liver Diseases, Liver Neoplasms, Liver Failure

NCT01088893 2012-05-24

Everolimus in Breast Cancer Patients After Pre-operative Chemotherapy

Phase 2 Unknown

Breast Neoplasms

NCT01525719 2012-02-03

CRAD001T

Phase 2 Unknown

Gastrointestinal

Cholangiocarcinoma

NCT01148628 2011-09-13

Dose-finding Study of CAELYXTM and RAD001 in Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Advanced Solid Tumors

NCT00930475 2011-01-26

Everolimus (RAD001) and Carboplatin in Pretreated Metastatic Breast Cancer

Phase 1/2 Unknown

Breast Neoplasms

NCT01175096 2010-08-04

Safety and Tolerability Profile of RAD001 Daily in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor

Phase 1/2 Unknown

Carcinoid Tumor, Neuroendocrine Tumors

NCT01079702 2010-03-03

m-TOR

Phase 1/2 Unknown

Advanced Malignancies

NCT00973713 2009-09-09

RADiChol

Phase 2 Unknown

Gastrointestinal

Cholangiocarcinoma

NCT00390195 2009-07-02

Randomized Phase I/II of RAD001 in Advanced Hepatocellular Carcinoma (HCC)

Phase 1/2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular

NCT00903188 2009-05-18

CISTCERT

Phase 4 Unknown

Neoplasms